241 related articles for article (PubMed ID: 7578498)
1. Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Dialysis.
Gokal R; Mistry CD; Peers EM
Perit Dial Int; 1995; 15(6):226-30. PubMed ID: 7578498
[TBL] [Abstract][Full Text] [Related]
2. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.
Mistry CD; Gokal R; Peers E
Kidney Int; 1994 Aug; 46(2):496-503. PubMed ID: 7967363
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled study of icodextrin on the treatment of peritoneal dialysis patients during acute peritonitis.
Chow KM; Szeto CC; Kwan BC; Pang WF; Ma T; Leung CB; Law MC; Li PK
Nephrol Dial Transplant; 2014 Jul; 29(7):1438-43. PubMed ID: 24578470
[TBL] [Abstract][Full Text] [Related]
6. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; van Dorp W; Peers EM; Verbrugh HA
Perit Dial Int; 1997; 17(6):602-7. PubMed ID: 9655161
[TBL] [Abstract][Full Text] [Related]
7. Specific characteristics of peritoneal leucocyte populations during sterile peritonitis associated with icodextrin CAPD fluids.
Glorieux G; Lameire N; Van Biesen W; Dequidt C; Vanholder R
Nephrol Dial Transplant; 2003 Aug; 18(8):1648-53. PubMed ID: 12897108
[TBL] [Abstract][Full Text] [Related]
8. Icodextrin: a review of its use in peritoneal dialysis.
Frampton JE; Plosker GL
Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
[TBL] [Abstract][Full Text] [Related]
9. Icodextrin use in CCPD patients during peritonitis: ultrafiltration and serum disaccharide concentrations.
Posthuma N; ter Weel PM; Donker AJ; Peers EM; Oe PL; Verbrugh HA
Nephrol Dial Transplant; 1998 Sep; 13(9):2341-4. PubMed ID: 9761519
[TBL] [Abstract][Full Text] [Related]
10. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
Canbakan M; Sahin GM
Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
[TBL] [Abstract][Full Text] [Related]
11. [Icodextrin in peritoneal dialysis therapy].
Grzegorzewska AE; Antczak-Jedrzejczak D
Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experience with icodextrin. Multicenter study].
Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Remón C; Fernández-Ruiz EJ; Pérez-Bañasco V; Benítez M; Martínez-Benavides E; Martínez-González JM; Torán D; Tejuca F; Páez C; del Pino MD
Nefrologia; 2001; 21(6):574-80. PubMed ID: 11881427
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
[TBL] [Abstract][Full Text] [Related]
14. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
[TBL] [Abstract][Full Text] [Related]
15. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.
Fourtounas C; Dousdampanis P; Hardalias A; Vlachojannis JG
Artif Organs; 2013 Jul; 37(7):E107-13. PubMed ID: 23461737
[TBL] [Abstract][Full Text] [Related]
16. Severe peritoneal mononucleosis associated with icodextrin use in continuous ambulatory peritoneal dialysis.
Martín J; Sansone G; Cirugeda A; Sánchez-Tomero JA; Muñoz C; Selgas R
Adv Perit Dial; 2003; 19():191-4. PubMed ID: 14763060
[TBL] [Abstract][Full Text] [Related]
17. Comparison of volume overload with cycler-assisted versus continuous ambulatory peritoneal dialysis.
Davison SN; Jhangri GS; Jindal K; Pannu N
Clin J Am Soc Nephrol; 2009 Jun; 4(6):1044-50. PubMed ID: 19406971
[TBL] [Abstract][Full Text] [Related]
18. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
[TBL] [Abstract][Full Text] [Related]
19. Sodium removal in patients undergoing CAPD and automated peritoneal dialysis.
Rodríguez-Carmona A; Fontán MP
Perit Dial Int; 2002; 22(6):705-13. PubMed ID: 12556073
[TBL] [Abstract][Full Text] [Related]
20. Icodextrin and intraperitoneal inflammation.
Moriishi M; Kawanishi H
Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
